Register entry
- Registered sites
- 1
- Active NDC listings
- 16
- Live patents
- 0
- Countries
- 1
- Base
- United States
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| GRANULATION TECHNOLOGY, INC. | 12 Industrial Road, FAIRFIELD, New Jersey (NJ) 07004, United States (USA) | Finished drug manufacture | 3001236066847132193 |
Catalogue
Drug listings by form and route
1616 active NDC listings: 12 human prescription drug, 4 human otc drug. By marketing category: ANDA 6, OTC MONOGRAPH DRUG 4, NDA 3, UNAPPROVED DRUG OTHER 3.
| Dosage form | NDCs |
|---|---|
| tablet | 9 |
| tablet, film coated | 5 |
| powder, for solution | 1 |
| tablet, orally disintegrating | 1 |
| Route | NDCs |
|---|---|
| oral | 14 |
| sublingual | 1 |
| topical | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| granulation technology, inc. | 16 |
Catalogue
Marketed products
16| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Astringent | Calcium acetate monohydrate and Aluminum sulfate tetradecahydrate | powder, for solution, topical | 63561-0178OTC MONOGRAPH DRUG |
| Carisoprodol Tablets, USP, 350 mg | Carisoprodol | tablet, oral | 63561-0127ANDA |
| Furosemide | FUROSEMIDE | tablet, oral | 63561-0164NDA |
| Furosemide | FUROSEMIDE | tablet, oral | 63561-0165NDA |
| Furosemide | FUROSEMIDE | tablet, oral | 63561-0166NDA |
| Hyoscyamine Sulfate | Hyoscyamine Sulfate | tablet, orally disintegrating, oral | 63561-0197UNAPPROVED DRUG OTHER |
| Hyoscyamine Sulfate | Hyoscyamine Sulfate | tablet, sublingual | 63561-0202UNAPPROVED DRUG OTHER |
| Hyoscyamine Sulfate | Hyoscyamine Sulfate | tablet, oral | 63561-0203UNAPPROVED DRUG OTHER |
| Laxative | Sennosides, 25 mg | tablet, film coated, oral | 63561-0186OTC MONOGRAPH DRUG |
| Methocarbamol Tablets, USP, 500 mg | Methocarbamol | tablet, film coated, oral | 63561-0173ANDA |
| Methocarbamol Tablets, USP, 750 mg | Methocarbamol | tablet, film coated, oral | 63561-0174ANDA |
| PredniSONE Tablets, USP, 10 mg | PredniSONE | tablet, oral | 63561-0121ANDA |
| PredniSONE Tablets, USP, 20 mg | PredniSONE | tablet, oral | 63561-0122ANDA |
| PredniSONE Tablets, USP, 5 mg | PredniSONE | tablet, oral | 63561-0120ANDA |
| Senna-S | DOCUSATE SODIUM, SENNOSIDES | tablet, film coated, oral | 63561-0187OTC MONOGRAPH DRUG |
| Vegetable Laxative | SENNOSIDES, 8.6 mg | tablet, film coated, oral | 63561-0188OTC MONOGRAPH DRUG |
Neighbours
Registered in the same town
7- SGS North America Inc.Fairfield, NJ
- Teva Pharmaceutical Industries Ltd.Fairfield, NJ
- API Solutions Inc.Fairfield, NJ
- Aarkish Pharmaceuticals NJ IncFairfield, NJ
- Akron Pharma Inc.Fairfield, NJ
- Garonit Pharmaceutical, Inc.Fairfield, NJ
- Leading Pharma, LLCFairfield, NJ
Compare
Comparable companies in United States
- Hahnemann Laboratories, Inc. dba Alpine Pharmaceuticals1 site · 4,853 NDC
- NuCare Pharmaceuticals,Inc.1 site · 1,393 NDC
- Greer Laboratories, Inc.1 site · 1,328 NDC
- ASCLEMED USA INC. DBA ENOVACHEM1 site · 789 NDC
- Golden State Medical Supply Inc.1 site · 670 NDC
- Rising Pharma Holdings, Inc.1 site · 532 NDC
- HF Acquisition Co LLC1 site · 363 NDC
- ANI Pharmaceuticals, Inc.1 site · 299 NDC
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.1 site · 273 NDC
- Newton Laboratories, Inc.1 site · 271 NDC
Enquiry
Common questions
- Is GRANULATION TECHNOLOGY, INC. FDA approved?
- GRANULATION TECHNOLOGY, INC. holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are GRANULATION TECHNOLOGY, INC.'s drugs manufactured?
- The FDA register lists FAIRFIELD, NJ. Registered operations: finished drug manufacture.
- What drugs does GRANULATION TECHNOLOGY, INC. make?
- 16 products are listed under GRANULATION TECHNOLOGY, INC. in the openFDA NDC Directory, most often as tablet; tablet, film coated; powder, for solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.